Morgan Stanley Discount Zert ISHA.../ DE000ME8H7H6 /
11.06.2024 17:46:22 | Diff.- | Geld10:08:57 | Brief10:08:57 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
105.48EUR | - | 105.29 Geld Vol: 75 |
105.35 Brief Vol: 75 |
- | - USD | 27.06.2025 | Call |
GlobeNewswire
10:00
Intech Unveils UCITS Fund with Adaptive Volatility and ESG Focus, Anchored by Norway’s Pension Schem...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation I...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
MBUU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Malibu Boats, Inc. Investors w...
GlobeNewswire
10:00
BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patient...
GlobeNewswire
09:01
AMERICAN SALARS COMPLETES PHASE 1 EXPLORATION OF BLACK ROCK SOUTH LITHIUM BRINE PROJECT, NV
GlobeNewswire
09:00
Nokia Report reveals enterprises are scaling private wireless for additional uses cases and industri...
GlobeNewswire
08:55
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite